Literature DB >> 26547386

Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.

Vikram Jairam1, James B Yu2.   

Abstract

PURPOSE: To use the Centers for Medicare and Medicaid Services Open Payments database to characterize payments made to radiation oncologists and compare their payment profile with that of medical and surgical oncologists. METHODS AND MATERIALS: The June 2015 release of the Open Payments database was accessed, containing all payments made to physicians in 2014. The general payments dataset was used for analysis. Data on payments made to medical, surgical, and radiation oncologists was obtained and compared. Within radiation oncology, data regarding payment category, sponsorship, and geographic distribution were identified. Basic statistics including mean, median, range, and sum were calculated by provider and by transaction.
RESULTS: Among the 3 oncologic specialties, radiation oncology had the smallest proportion (58%) of compensated physicians and the lowest mean ($1620) and median ($112) payment per provider. Surgical oncology had the highest proportion (84%) of compensated physicians, whereas medical oncology had the highest mean ($6371) and median ($448) payment per physician. Within radiation oncology, nonconsulting services accounted for the most money to physicians ($1,042,556), whereas the majority of the sponsors were medical device companies (52%). Radiation oncologists in the West accepted the most money ($2,041,603) of any US Census region.
CONCLUSIONS: Radiation oncologists in 2014 received a large number of payments from industry, although less than their medical or surgical counterparts. As the Open Payments database continues to be improved, it remains to be seen whether this information will be used by patients to inform choice of providers or by lawmakers to enact policy regulating physician-industry relationships.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26547386     DOI: 10.1016/j.ijrobp.2015.09.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.

Authors:  Susan F Wood; Joanna Podrasky; Meghan A McMonagle; Janani Raveendran; Tyler Bysshe; Alycia Hogenmiller; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

2.  Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.

Authors:  William Fleischman; Shantanu Agrawal; Marissa King; Arjun K Venkatesh; Harlan M Krumholz; Douglas McKee; Douglas Brown; Joseph S Ross
Journal:  BMJ       Date:  2016-08-18

Review 3.  Choosing wisely in oncology: necessity and obstacles.

Authors:  Piercarlo Saletti; Piero Sanna; Luca Gabutti; Michele Ghielmini
Journal:  ESMO Open       Date:  2018-07-11

4.  Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.

Authors:  Julius K Weng; Luca F Valle; Gina E Nam; Fang-I Chu; Michael L Steinberg; Ann C Raldow
Journal:  JAMA Netw Open       Date:  2019-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.